Table 3

Number of patients in the study cohort with CVD outcomes of interest by outcome subtype

MIStrokeHeart failure
MICADMINOCAEmbolicIschaemicHaemorrhagic
PPCM (n=558)<10*<10*<10*<10*056
Chronic HTN (n=12 458)14<10*<10*28<10*152
Gestational HTN (n=43 073)<10*<10*<10*22<10*188
Pre-eclampsia (n=56 419)16<10<106014355
Chronic HTN and gestational HTN (n=4907)<10*0<10*<10*<10*45
Chronic HTN and pre-eclampsia (n=5743)<10*0<10*35<10*135
Gestational DM (n=107 636)24<10*126229320
Preterm birth (n=116 768)4215139625532
IUGR (n=23 504)<10*<10*<10*17<10*86
Total1264053333911251
  • *In accordance with HCUP policies, categories in which there were fewer than 10 patients are represented simply as <10.

  • CVD, cardiovascular disease; DM, diabetes mellitus;HCUP, Healthcare Cost and Utilization Project; HTN, hypertension;IUGR, intrauterine growth restriction; MI, myocardial infarction;MICAD, MI with obstructive coronary artery disease;MINOCA, MI without obstructive coronary artery disease;PPCM, peripartum cardiomyopathy.